Sep 9, 2016
Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company
Featuring: Peter Wilcox, Jason Markwell, Stephanie Anderson and Stefanie Di Giandomenico
Following a six week trial, we obtained a judgment finding that Bayer’s patent covering YAZ and Yasmin birth control products was valid and infringed and permanently enjoining Apotex and Cobalt from selling their generic products. The trial judge rejected all of Apotex’s numerous validity attacks and found that Bayer had shown that the Apotex and Cobalt products infringe the patent.